Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D09BZY
|
|||
Former ID |
DIB013761
|
|||
Drug Name |
Nibentan
|
|||
Synonyms |
HE-11; Rac-N-[5-(Diethylamino)-1-phenylpentyl]-4-nitrobenzamide hydrochloride
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Cardiac arrhythmias [ICD-11: BC9Z; ICD-9: 427] | Phase 1 | [1] | |
Structure |
Download2D MOL |
|||
Formula |
C22H30ClN3O3
|
|||
Canonical SMILES |
CCN(CC)CCCCC(C1=CC=CC=C1)NC(=O)C2=CC=C(C=C2)[N+](=O)[O-].Cl
|
|||
InChI |
1S/C22H29N3O3.ClH/c1-3-24(4-2)17-9-8-12-21(18-10-6-5-7-11-18)23-22(26)19-13-15-20(16-14-19)25(27)28;/h5-7,10-11,13-16,21H,3-4,8-9,12,17H2,1-2H3,(H,23,26);1H
|
|||
InChIKey |
CHCBAYRWJULIDW-UHFFFAOYSA-N
|
|||
CAS Number |
CAS 157832-56-9
|
|||
PubChem Compound ID | ||||
PubChem Substance ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Potassium channel unspecific (KC) | Target Info | Blocker | [2], [3] |
References | Top | |||
---|---|---|---|---|
REF 1 | Electrophysiologic effects of nibentan (HE-11) on canine cardiac tissue. J Pharmacol Exp Ther. 1997 Mar;280(3):1137-46. | |||
REF 2 | Nibentan -- a drug for pharmacological cardioversion of persistent atrial fibrillation. Kardiologiia. 2005;45(3):19-23. | |||
REF 3 | Therapeutic target database update 2012: a resource for facilitating target-oriented drug discovery. Nucleic Acids Res. 2012 Jan;40(Database issue):D1128-36. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.